the rocky road from efficacy to effectiveness: overview and critique of cer

24
The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Upload: diza

Post on 13-Jan-2016

18 views

Category:

Documents


1 download

DESCRIPTION

The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER. Ian D. Coulter Ph.D. RAND/Samueli Chair in Integrative Medicine & Senior Health Policy Scientist, RAND Corporation; Professor, UCLA; Adjunct Research Faculty, Southern California University of Health Sciences. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

The Rocky Road from Efficacy to Effectiveness: Overview and Critique of

CER

Page 2: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Ian D. Coulter Ph.D.RAND/Samueli Chair in Integrative Medicine & Senior Health Policy Scientist, RAND Corporation; Professor, UCLA; Adjunct Research Faculty, Southern California University of Health Sciences

Page 3: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

CERComparative Effectiveness

Research (CER)

IOM DEFINITION

Effectiveness Research (CER)

Comparison of effectiveness of interventions among patients in a typical patient care setting with decisions tailored to individual need. Pragmatic trials (as opposed to explanatory) Head to head trials

What is CER

Page 4: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Efficacy Vs Effectiveness

Efficacy Tests a therapy under ideal conditions using the RCT. But practice ultimately needs therapy that works under normal practice i.e. effectiveness studies. A therapy that has efficacy may not be effective and those of equal efficacy may not have equal effectiveness. Effectiveness must take into account the total health encounter and must be grounded in what actually occurs in the encounter.

Page 5: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

NIH

The American Recovery and Reinvestment Act of 2009 (generally referred to as the stimulus package), has allocated $1.1 billion “down payment” to fund comparative effectiveness research

So that is real money

Page 6: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

So how is this money to be spent?

$300 million for the Agency for Healthcare Research and Quality

(AHRQ), $400 million for the National Institutes of Health, and $400 million

for allocation at the discretion of the Secretary

of Health and Human Services

Page 7: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Agency for Health Research Quality

Effective Health Care Program whose purpose is to fund research that provides reliable and practical data that can inform decisions in clinical practice.

AHRQ

Page 8: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

National Center for Complementary and Alternative Medicine

Request for research proposals for Comparative Effectiveness Studies of Complementary and Alternative Medicine.

Observational studies or secondary data analyses to compare the effectiveness or cost-effectiveness of:

1) CAM used in addition to standard conventional care

2) CAM or integrative health care versus standard conventional care

3) one CAM therapy to another

NCCAM

Page 9: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

The GoodThe move away from privileging RCTs above all other evidence

Recognition that RCTs do not answer questions of effectiveness

Placing the interests of patients and providers above or equal to that of scientists

A recognition of the role of observational data

Solves some of the ethical

issues around RCTs

Solves some of the methodological challenges of RCTs in CAM

Average patients with average providers in average clinic

Moves us towards whole systems research

Puts the “P” back into “EBP”

Page 10: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

The Bad

• Still a bit focused on “trials” • Does not go far enough• Does not get at the health

encounter• Problem of replication

Page 11: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

The Weakness of CER

1. To the extent the provider is free to do what they want, it is difficult to know what was done

2. To the extent we do not know what was done we do not know what contributes to the outcome

3. To the extent we do not know what was done we do not know what to replicate or how to do so

Page 12: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Descriptive StudiesIn the most CER cases we lack a body of descriptive studies that would tell us what the treatment & the health encounter includes. We are not even sure about how we might collect such data or what is important to collect

Page 13: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

So what can we do?

1) Health Services research on

effectiveness2) Observation

studies

Page 14: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Health Services Research

“Investigation of the relationship between social structure, process and outcomes for personal health services, a transaction between a client and a provider to promote health”

Institute for Medicine 1979. HSR focuses on the total organization of health care.

Page 15: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Links structure, process & outcomesMeasure quality of careEvaluates access, cost, utilization & servicesMeasures health care need and risksDetermines patient values & satisfaction & HRQOLDetermines appropriateness of careDetermines effectiveness of careUses methods beyond RCTs – e.g. program evaluationIs multi-disciplinary

Heath Services Research

Page 16: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

HSR with its focus on linking outcomes to structure and process, its work on cost and cost benefit introduces a badly needed dose of realism into the EBP movement and to CER.

Page 17: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

17

 

IKEA HAS ANNOUNCED IT'S INTENTION  TO TAKE OVER GM, AND TO SELL CARS.

 

 

 

  

Page 18: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Observation Studies

Stroup et al. “an effectiveness

study using data from an existing data base, a cross sectional study, a case series, a case control design, a design with historical controls, or a cohort design”

Challenges

1. No randomization

2. Cannot measure efficacy

3. Cannot assess bias

4. Cannot be pooled for analysis

Page 19: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Sociological Anthropological Observation Studies

Participant observation studiesRapid ethnographic observationContextual analysisSocial/cultural contextNegotiation MeaningHealth Encounter as the unit of analysis

and as a contributor to outcomesProvide understanding for effectivenessChiropractic HSR vs Social science

observation

Page 20: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Chiropractic HSR vs Social science observation

HSR

• Musculoskeletal specialists

• Narrow scope

• Manipulation

• Back problems

Ethnographic Observations

1.Holistic

2.Broad scope

3.Wellness practitioners

Page 21: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Conclusion

• The money is great

• The focus is better

• The promise is good but we are still not sure about the delivery

• On paper it is good news

• But it needs to go further

Page 22: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

Dedicated to Sir David Low and COLONEL BLIMP

“Gad, sir, reforms are all right as long as

they don't change

anything.'

Page 23: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

References

• Zwarenstein M, Treweek S. What kind of randomized trials do we need? CMAJ May 12, 2009; 180(10): 998-1000.

• Luce BR, Kramer JM, Goodman SN, Connor J, Tunis S, Whicker D, Schwartz S. Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change. Annals of Internal Medicine, August 4, 2009; 151(3): 206-209.

• Thorpe KE, A Pragmatic-Explanatory Continuum Indicator Summary (PRECIS). Dalla Lana School of Public Health. May 8, 2009.

• Sox H., Greenfield S. Comparative Effectiveness Research: A Report From the Institute of Medicine. Annals of Internal Medicine, 2009; 151: 203-205.

• Chiappelli F, Cajulis O, Newman M. Comparative Effectiveness Research in Evidence-Based Dental Practice. J Evid Base Dent Pract 2009; 9: 57-58.

Page 24: The Rocky Road from Efficacy to Effectiveness: Overview and Critique of CER

References• Coulter ID, Khorsan R. Chapter 7, Health Services Research. IN Lewith G,

Jonas W, Walach H (Eds.) Clinical Research in Complementary Therapies 2c. Elsevier; Oxford, England

• Coulter ID, Khorsan R. Is Health Services Research the Holy Grail of CAM Research? (Review Article) Alternative Therapies Health Med 2007. Altern Ther Health Med. 2008 July/Aug;14(4):40-5.

• Coulter ID. Competing Views of Chiropractic: Health Services Research versus Ethnographic Observation. Chapter 3 IN: Oths KS, Hinojosa SZ (eds). Healing by Hand. Manual Medicine and Bonesetting in Global Perspective. AltaMira Press: Walnut Creek, CA, 2004.

• Coulter ID. Comparative Effectiveness Research: Does the Emperor Have Clothes? Alternative Therapies Health Med 2011; 17(2):8-15.

• Coulter ID, Khorsan R. Health Services Research as a Form of Evidence for CAM?  In: Lewith G, Jonas W, Walach H (Eds.) Clinical Research in Complementary Therapies, 2nd edition. Elsevier; Oxford, England; Chapter 7 pages 119-134, 2011.

• Linde K, Coulter ID.   Systematic reviews and meta-analyses. In: Lewith G, Jonas W, Walach H (Eds.) Clinical Research in Complementary Therapies, 2nd edition.  Elsevier; Oxford, England. 2011.